Brain Tumor Induced Immunosuppression

Overview

About this study

The purpose of this study is to determine the presence of immunosuppressive molecules and immunosuppressive leukocytes in brain tumor patients’ blood.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria:

  • Patients 18 and older with treated and untreated brain tumors.
  • Pathologically or radiologically diagnosed intracranial brain tumors

Exclusion Criteria: 

  • Patients 17 years and younger.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ian Parney, M.D., Ph.D.

Open for enrollment

Contact information:

Ravi Kumar M.D.

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20306516

Mayo Clinic Footer